• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 07 Aug 2026

Trim Price Target To $93 (From $100) Following 2Q:26 EPS Miss And Lowered Guidance; Bookings And Backlog Continue To Grow, Powered By North American Robotics Demand


Tennant Company (TNC:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Steve Ferazani

    • 11 pages


 

We trim our price target to $93 (from $100) following a 2Q:26 EPS miss, despite revenue growth above our projection, as margins were narrower than we forecast on North American ERP stabilization costs and inflationary pressure, particularly in EMEA. Revenue expanded about 2% year over year to $324 million, about 2% ahead of our estimate, on pricing and growing North American robotics sales (up 37% year over year), offsetting soft conditions in EMEA and APAC, and component shortages. Bookings increased almost 7% (on strength across all regions) with backlog up $18 million sequentially to $127 million, indicating continued healthy demand. Management is targeting full year 2026 robotics sales of $130-$145 million (from $85 million in 2025), benefiting from the launch of two new cleaners in 2H:26, and $250 million in 2028, supported by further product rollouts and channel expansion. 2Q:26 EPS of $0.83 missed our $1.18 estimate (consensus $1.33), almost entirely due to elevated SG&A costs, on inflationary pressures and continued elevated ERP expenses (as well as increasing R&D investments). Despite solid demand and modestly raised revenue guidance, management reduced full year EPS guidance to $3.80-$4.45 (from $4.70-$5.30) on higher costs. We model a robust EPS recovery in 2027 powered by healthy booking trends, growing robotics sales, and more normalized margins. However, we model a slower recovery and reduce our 2027 EPS forecast to $5.82 (from $6.60). Despite North American ERP implementation issues beginning in 4Q:25, which had hampered deliveries and raised costs, the balance sheet remains solid, with net leverage of only 2.0x at the end of 2Q:26 (at the high end of management's target). Our lowered $93 price target (from $100) is based on 16x our revised 2027 EPS estimate of $5.82 (from $6.60). It was previously based on 17x our former average 2026-2027 EPS forecast of $5.86. The lower multiple reflects the longer time horizon and current forward multiple for our industrial machinery peer group. Our moderate risk rating is supported by growing bookings and the solid balance sheet.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Trim Price Target To $93 (From $100) Following 2Q:26 EPS Miss And Lowered Guidance; Bookings And Backlog Continue To Grow, Powered By North American Robotics Demand


Tennant Company (TNC:NYSE) | 0 0 0.0%


  • Published: 07 Aug 2026
  • Author: Steve Ferazani
  • Pages: 11
  • Sidoti & Company


We trim our price target to $93 (from $100) following a 2Q:26 EPS miss, despite revenue growth above our projection, as margins were narrower than we forecast on North American ERP stabilization costs and inflationary pressure, particularly in EMEA. Revenue expanded about 2% year over year to $324 million, about 2% ahead of our estimate, on pricing and growing North American robotics sales (up 37% year over year), offsetting soft conditions in EMEA and APAC, and component shortages. Bookings increased almost 7% (on strength across all regions) with backlog up $18 million sequentially to $127 million, indicating continued healthy demand. Management is targeting full year 2026 robotics sales of $130-$145 million (from $85 million in 2025), benefiting from the launch of two new cleaners in 2H:26, and $250 million in 2028, supported by further product rollouts and channel expansion. 2Q:26 EPS of $0.83 missed our $1.18 estimate (consensus $1.33), almost entirely due to elevated SG&A costs, on inflationary pressures and continued elevated ERP expenses (as well as increasing R&D investments). Despite solid demand and modestly raised revenue guidance, management reduced full year EPS guidance to $3.80-$4.45 (from $4.70-$5.30) on higher costs. We model a robust EPS recovery in 2027 powered by healthy booking trends, growing robotics sales, and more normalized margins. However, we model a slower recovery and reduce our 2027 EPS forecast to $5.82 (from $6.60). Despite North American ERP implementation issues beginning in 4Q:25, which had hampered deliveries and raised costs, the balance sheet remains solid, with net leverage of only 2.0x at the end of 2Q:26 (at the high end of management's target). Our lowered $93 price target (from $100) is based on 16x our revised 2027 EPS estimate of $5.82 (from $6.60). It was previously based on 17x our former average 2026-2027 EPS forecast of $5.86. The lower multiple reflects the longer time horizon and current forward multiple for our industrial machinery peer group. Our moderate risk rating is supported by growing bookings and the solid balance sheet.

More Content

More Content

Anticipate Sequential Quarterly EPS Ramp Through 2026 On New Robotic Rollouts And North American ERP Evolution From Stabilization To Optimization; Maintain $100 Price Target

Companies: Tennant Company

Sidoti & Company

Modestly Raise 2H:25 And 2026 EPS Estimates On Order Growth And The Expanding Product Lineup, Despite 2Q:25 EPS Miss; Maintain $115 Price Target

Companies: Tennant Company

Sidoti & Company

Conference Takeaways: Raise Price Target To $100 (From $92) As We Expect ERP Implementation Issues Are Largely Resolved And Remain Bullish On Robotic Opportunities

Companies: Tennant Company

Sidoti & Company

Management Highlighted Ongoing Product Development At Sidoti's Virtual Conference; Maintain $115 Price Target; Expect 2H:25 EPS Improvement On New Order Growth And Cost Outs

Companies: Tennant Company

Sidoti & Company

Bump Price Target Up To $92 (From $87) On Strong Orders As TNC Appears To Be Progressing Through ERP Issues And Expands Share Buyback Authorization

Companies: Tennant Company

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2026

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Allenby Capital
      • Alternative Resource Capital
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • EM Spreads
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • Greenwood Capital Partners
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Morphose Capital Partners
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Primary Portal
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS Research Group
      • RBC Capital Markets
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Curious Compounder
      • The Edge Group
      • The Investor Summit
      • The Life Sciences Division
      • ThinkFront
      • Ticker TV
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Venn Brown
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • AlphaValue
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In